Elke Niebergall-Roth

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Cross Sectional

Replacement Therapy

Top Venues

JID innovations

This page only lists publications with an associated author ORCID identifier.

Publications

Hannes M Schröder, Elke Niebergall-Roth, Alexandra Norrick, Jasmina Esterlechner, Christoph Ganss, Markus H Frank, Mark A Kluth
Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. Cells 12 (13) (2023)
Elke Niebergall-Roth, Kathrin Dieter, Cristina Daniele, Silvia Fluhr, Maria Khokhrina, Ines Silva, Christoph Ganss, Markus H Frank, Mark A Kluth
Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5 + Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa. Cells 12 (11) (2023)
Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, Ann-Kathrin Dachtler, Korinna Kraft, Markus Stücker, Georg Daeschlein, Michael Jünger, Tobias Goerge, Ulrich Meyer-Pannwitt, Cornelia Erfurt-Berge, Charlotte von Engelhardt, Andreas Klare, Christiane Pfeiffer, Jasmina Esterlechner, Hannes M Schröder, Martin Gasser, Ana Maria Waaga-Gasser, Matthias Goebeler, Seda Ballikaya, Samar Sadeghi, George F Murphy, Dennis P Orgill, Natasha Y Frank, Christoph Ganss, Karin Scharffetter-Kochanek, Markus H Frank, Mark Andreas Kluth
Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial. JID innovations 2 (1) (2021)